B Angus Selected Research

B Angus Research Topics

Disease

5	Hodgkin Disease (Hodgkin's Disease) 01/2003 - 05/2000
4	Lymphoma (Lymphomas) 11/2006 - 07/2001
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2006 - 01/2000
2	Bacterial Infections (Bacterial Infection) 04/2011 - 01/2001
2	Neoplasms (Cancer) 07/2003 - 04/2002
2	Genomic Instability 07/2003 - 08/2000
2	Breast Neoplasms (Breast Cancer) 07/2003 - 04/2003
2	Falciparum Malaria (Plasmodium falciparum Malaria) 12/2001 - 08/2000
1	HIV Infections (HIV Infection) 04/2011
1	Pneumonia (Pneumonitis) 04/2011
1	Bacterial Pneumonia 04/2011
1	Infections 06/2009
1	Staphylococcal Infections 06/2009
1	Colorectal Neoplasms (Colorectal Cancer) 05/2008
1	Neoplasm Metastasis (Metastasis) 05/2008
1	Pathologic Constriction (Stenosis) 01/2007
1	Hypoxia (Hypoxemia) 01/2007
1	Common Variable Immunodeficiency 11/2003
1	Carcinoma (Carcinomatosis) 07/2003
1	Melanoma (Melanoma, Malignant) 04/2002
1	Neutropenia 01/2002
1	Acute malaria 12/2001
1	Persistent Infection 04/2001
1	Melioidosis 01/2001
1	Gram-Negative Bacterial Infections 01/2001
1	Transitional Cell Carcinoma 01/2001
1	Malaria 08/2000
1	Septic Shock (Toxic Shock Syndrome) 03/2000
1	Sepsis (Septicemia) 03/2000
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2000

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 05/2008 - 01/2001
4	Etoposide (VP 16)FDA LinkGeneric 01/2003 - 05/2000
3	Chlorambucil (Leukeran)FDA Link 11/2006 - 01/2000
3	Protein Isoforms (Isoforms)IBA 07/2003 - 08/2000
3	Epirubicin (Ellence)FDA LinkGeneric 01/2003 - 05/2000
3	Ifosfamide FDA LinkGeneric 01/2003 - 05/2000
3	AntigensIBA 02/2002 - 02/2000
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2009 - 01/2001
2	Immunoglobulin G (IgG)IBA 01/2007 - 11/2003
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 11/2006 - 01/2000
2	Dexamethasone (Maxidex)FDA LinkGeneric 11/2006 - 01/2000
2	artemisinin (artemisinine)IBA 12/2001 - 08/2000
2	ArtesunateIBA 12/2001 - 08/2000
2	Antimalarials (Antimalarial Agents)IBA 12/2001 - 08/2000
1	EsapentIBA 04/2011
1	Interleukin-2 (IL2)IBA 04/2011
1	CytokinesIBA 04/2011
1	Fluorouracil (Carac)FDA LinkGeneric 05/2008
1	Immunoglobulins (Immunoglobulin)IBA 11/2003
1	Messenger RNA (mRNA)IBA 07/2003
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2003
1	Biomarkers (Surrogate Marker)IBA 04/2003
1	Growth Factor ReceptorsIBA 04/2003
1	Procarbazine (Matulane)FDA Link 04/2002
1	Prednisolone (Predate)FDA LinkGeneric 04/2002
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2002
1	Bleomycin (Blenoxane)FDA LinkGeneric 04/2002
1	Vinblastine (Vinblastine Sulfate)FDA Link 04/2002
1	Vincristine (Oncovin)FDA LinkGeneric 04/2002
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2002
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2002
1	Artemether FDA Link 12/2001
1	Cyclin D1IBA 01/2001
1	Surface Antigens (Surface Antigen)IBA 08/2000
1	Quinine (Quinson)FDA Link 08/2000
1	platelet activating factor receptorIBA 03/2000
1	lexipafantIBA 03/2000
1	Platelet Activating FactorIBA 03/2000
1	ParaffinIBA 02/2000
1	CD5 AntigensIBA 02/2000
1	Formaldehyde (Formol)FDA Link 02/2000
1	AntibodiesIBA 02/2000
1	Monoclonal AntibodiesIBA 02/2000
1	AnthracyclinesIBA 01/2000

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 04/2002 - 05/2000
1	Highly Active Antiretroviral Therapy (HAART) 04/2011
1	Debridement 06/2009
1	Adjuvant Chemotherapy 05/2008
1	Time-to-Treatment 11/2006
1	Salvage Therapy 01/2003
1	Therapeutics 07/2001
1	Aftercare (After-Treatment) 08/2000
1	Stem Cell Transplantation 05/2000